Evidence map›Paper›PMID 41230560›Full record

ArticlePhysical chemistry chemical physics : PCCP2025

Specific and non-specific interactions of fibronectin with zwitterionic peptoid brushes studied by molecular dynamics simulation.

David L Cheung, Phillip B Messersmith, King Hang Aaron Lau

Abstract read
In one paragraph

Article in Physical chemistry chemical physics : PCCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David L CheungSchool of Biological and Chemical Sciences, University of Galway, Galway, Ireland. david.cheung@universityofgalway.ie.ORCID http://orcid.org/0000-0002-3994-2295
Phillip B MessersmithDepartment of Bioengineering, University of California, Berkeley, USA.ORCID http://orcid.org/0000-0002-1197-333X
King Hang Aaron LauDepartment of Pure and Applied Chemistry, University of Strathclyde, Glasgow, UK. aaron.lau@strathclyde.ac.uk.ORCID http://orcid.org/0000-0003-3676-9228

Funding

Antifouling Peptide Mimetic PolymersR01EB005772 · NIBIB · NORTHWESTERN UNIVERSITY · PI MESSERSMITH, PHILLIP B, SZLEIFER, IGAL G · 2008 to 2016
$2.8M
Zero Net Charge Polymer Brush Surfaces Highly Resistant to Protein AdsorptionF32HL104966 · NHLBI · NORTHWESTERN UNIVERSITY · PI LAU, K. H. AARON · 2011 to 2012
$105k
NHLBI NIH HHS F32 HL104966NIBIB NIH HHS R01 EB005772
6 · The paper itself

Abstract

Zwitterionic polymer brushes represent a prominent class of surfaces to prevent non-specific protein interactions. However, residual protein binding and cell attachment can still be observed. Peptide-mimetic "peptoids" constitute a versatile sequence-specific platform for developing specific protein binding motifs as well as antifouling brushes. Nonetheless, molecular level insight into their protein interactions is generally lacking. Using atomistic molecular dynamics (MD) simulation, we analyse the interactions of fibronectin type-III (FnIII) 9- and 10-domains with a zwitterionic peptoid brush and compare it with polysarcosine, the well-known and uncharged elementary peptoid and potential PEG replacement. Experimental protein adsorption trends are used to determine the peptoid chain densities simulated. For each combination of peptoid and chain density, 9 independent simulations with different starting protein orientations are performed. The simulation results are consistent with experimental measurements over different chain densities, and they identified FnIII

Indexed as

FibronectinsMolecular Dynamics SimulationPeptoidsPeptidesProtein BindingSarcosineFibronectinsPeptidesPeptoidspolysarcosineSarcosine

Identifiers

PMID41230560
PMCPMC12612986

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.